{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:59:37Z","timestamp":1768784377983,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T00:00:00Z","timestamp":1370563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00228-013-1512-x","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T08:42:55Z","timestamp":1370508175000},"page":"1747-1755","source":"Crossref","is-referenced-by-count":8,"title":["Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study"],"prefix":"10.1007","volume":"69","author":[{"name":"on behalf of the Norwegian Heart Failure Registry steering committee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Frankenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. A.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grundtvig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"de Blois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schellberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Atar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Zugck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Agewall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,7]]},"reference":[{"issue":"14","key":"1512_CR1","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787\u20131847","journal-title":"Eur Heart J"},{"issue":"14","key":"1512_CR2","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):e391\u2013e479","journal-title":"Circulation"},{"issue":"1","key":"1512_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1):11\u201321. doi: 10.1056\/NEJMoa1009492","journal-title":"N Engl J Med"},{"issue":"14","key":"1512_CR4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309\u20131321. doi: 10.1056\/NEJMoa030207","journal-title":"N Engl J Med"},{"issue":"10","key":"1512_CR5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709\u2013717. doi: 10.1056\/NEJM199909023411001","journal-title":"N Engl J Med"},{"issue":"4","key":"1512_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/eurheartj\/ehp026","volume":"30","author":"B Pitt","year":"2009","unstructured":"Pitt B (2009) Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction. Eur Heart J 30(4):387\u2013388","journal-title":"Eur Heart J"},{"issue":"7","key":"1512_CR7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0300-8932(10)70180-9","volume":"63","author":"J Sanchez-Mas","year":"2010","unstructured":"Sanchez-Mas J, Turpin MC, Lax A, Ruiperez JA, Valdes Chavarri M, Pascual-Figal DA (2010) Differential actions of eplerenone and spironolactone on the protective effect of testosterone against cardiomyocyte apoptosis in vitro. Rev Esp Cardiol 63(7):779\u2013787","journal-title":"Rev Esp Cardiol"},{"issue":"5","key":"1512_CR8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2010.04.024","volume":"160","author":"M Yamaji","year":"2010","unstructured":"Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie M (2010) Effect of eplerenone versus spironolactone on cortisol and hemoglobin A(c) levels in patients with chronic heart failure. Am Heart J 160(5):915\u2013921","journal-title":"Am Heart J"},{"issue":"6","key":"1512_CR9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/eurjhf\/hfq047","volume":"12","author":"L Frankenstein","year":"2010","unstructured":"Frankenstein L, Remppis A, Fluegel A, Doesch A, Katus HA, Senges J, Zugck C (2010) The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex. Eur J Heart Fail 12(6):574\u2013580","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"1512_CR10","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19):2388\u20132442","journal-title":"Eur Heart J"},{"issue":"12","key":"1512_CR11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/pds.968","volume":"13","author":"DB Rubin","year":"2004","unstructured":"Rubin DB (2004) On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 13(12):855\u2013857. doi: 10.1002\/pds.968","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1512_CR12","unstructured":"Love TE (2009) Using propensity scores: stratification, adjustment, sensitivity and strategies. http:\/\/www.chrp.org\/propensity\/ . Accessed 4 June 2005"},{"issue":"1","key":"1512_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","volume":"51","author":"PC Austin","year":"2009","unstructured":"Austin PC (2009) Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J 51(1):171\u2013184. doi: 10.1002\/bimj.200810488","journal-title":"Biom J"},{"issue":"11","key":"1512_CR14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/eurheartj\/ehm091","volume":"28","author":"A Ahmed","year":"2007","unstructured":"Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, Pitt B (2007) A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28(11):1334\u20131343","journal-title":"Eur Heart J"},{"issue":"4","key":"1512_CR15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","volume":"54","author":"ST Normand","year":"2001","unstructured":"Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, McNeil BJ (2001) Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54(4):387\u2013398","journal-title":"J Clin Epidemiol"},{"key":"1512_CR16","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3692-2","volume-title":"Observational studies","author":"PR Rosenbaum","year":"2002","unstructured":"Rosenbaum PR (2002) Observational studies, 2nd edn. Springer, Berlin Heidelberg","edition":"2"},{"key":"1512_CR17","volume-title":"Spreadsheet-based sensitivity analysis calculations for matched samples","author":"TE Love","year":"2008","unstructured":"Love TE (2008) Spreadsheet-based sensitivity analysis calculations for matched samples. Center for Health Care Research & Policy, Case Western Reserve University, Cleveland"},{"issue":"6","key":"1512_CR18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","volume":"351","author":"DN Juurlink","year":"2004","unstructured":"Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351(6):543\u2013551. doi: 10.1056\/NEJMoa040135","journal-title":"N Engl J Med"},{"key":"1512_CR19","doi-asserted-by":"crossref","first-page":"c1768","DOI":"10.1136\/bmj.c1768","volume":"340","author":"L Wei","year":"2010","unstructured":"Wei L, Struthers AD, Fahey T, Watson AD, Macdonald TM (2010) Spironolactone use and renal toxicity: population based longitudinal analysis. BMJ 340:c1768. doi: 10.1136\/bmj.c1768","journal-title":"BMJ"},{"issue":"1","key":"1512_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.104.527549","volume":"112","author":"FA Masoudi","year":"2005","unstructured":"Masoudi FA, Gross CP, Wang Y, Rathore SS, Havranek EP, Foody JM, Krumholz HM (2005) Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998\u20132001. Circulation 112(1):39\u201347. doi: 10.1161\/CIRCULATIONAHA.104.527549","journal-title":"Circulation"},{"issue":"3","key":"1512_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cardfail.2006.01.003","volume":"12","author":"DT Ko","year":"2006","unstructured":"Ko DT, Juurlink DN, Mamdani MM, You JJ, Wang JT, Donovan LR, Tu JV (2006) Appropriateness of spironolactone prescribing in heart failure patients: a population-based study. J Card Fail 12(3):205\u2013210. doi: 10.1016\/j.cardfail.2006.01.003","journal-title":"J Card Fail"},{"issue":"4","key":"1512_CR22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/eurheartj\/ehn543","volume":"30","author":"JA Ezekowitz","year":"2009","unstructured":"Ezekowitz JA, McAlister FA (2009) Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J 30(4):469\u2013477","journal-title":"Eur Heart J"},{"key":"1512_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/JAHA.111.000018","volume":"1","author":"GC Fonarow","year":"2012","unstructured":"Fonarow GC, Alber NM, Curtis AB, Gheorghiade M, Liu Y, Mehra MR, O\u2019Conor CM, Reynolds D, Walsh MN, Yancy CW (2012) Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case\u2013control analysis of improve HF. J Am Heart Assoc 1:16\u201320. doi: 10.1161\/JAHA.111.000018","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1512_CR24","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.amjcard.2010.06.052","volume":"106","author":"E Vizzardi","year":"2010","unstructured":"Vizzardi E, D\u2019Aloia A, Giubbini R, Bordonali T, Bugatti S, Pezzali N, Romeo A, Dei Cas A, Metra M, Dei Cas L (2010) Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure. Am J Cardiol 106(9):1292\u20131296","journal-title":"Am J Cardiol"},{"issue":"4","key":"1512_CR25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejheart.2006.10.005","volume":"9","author":"C Berry","year":"2007","unstructured":"Berry C, Murphy NF, De Vito G, Galloway S, Seed A, Fisher C, Sattar N, Vallance P, Hillis WS, McMurray J (2007) Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. Eur J Heart Fail 9(4):429\u2013434","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1512_CR26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ahj.2010.08.036","volume":"160","author":"S Hamaguchi","year":"2010","unstructured":"Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto K, Goto D, Yokota T, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H (2010) Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure. Am Heart J 160(6):1156\u20131162","journal-title":"Am Heart J"},{"issue":"3","key":"1512_CR27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cardfail.2006.11.016","volume":"13","author":"M Ouzounian","year":"2007","unstructured":"Ouzounian M, Hassan A, Cox JL, Johnstone DE, Howlett J (2007) The effect of spironolactone use on heart failure mortality: a population-based study. J Card Fail 13(3):165\u2013169","journal-title":"J Card Fail"},{"issue":"4","key":"1512_CR28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2885.2010.01235.x","volume":"34","author":"S Schuller","year":"2011","unstructured":"Schuller S, Van Israel N, Vanbelle S, Clercx C, McEntee K (2011) Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs. J Vet Pharmacol Ther 34(4):322\u2013331. doi: 10.1111\/j.1365-2885.2010.01235.x","journal-title":"J Vet Pharmacol Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-013-1512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-013-1512-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-013-1512-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:49:03Z","timestamp":1558702143000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-013-1512-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,7]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["1512"],"URL":"https:\/\/doi.org\/10.1007\/s00228-013-1512-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,7]]}}}